ArticleDigestive diseases and sciences2026
Children with Autism Spectrum Disorder and Chronic Gastrointestinal Symptoms Have Alterations in Intestinal Neurotransmitter Pathways.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sex-specific neurological dysregulation may underpin distinctly different male and female behavioural phenotypes in a zebrafish model of autism spectrum disorder.Behavioral and brain functions : BBF · 2026Article
- Linking Genetic Risk to Disease-Relevant Cellular States via Metacell-Informed Modeling with ICePop.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND AND
aimsEmerging evidence supports a strong bidirectional relationship between the gastrointestinal system and the central nervous system, referred to as the gut-brain axis. This axis has been proposed to be of particular importance in the context of neurodevelopmental disorders including autism spectrum disorder (ASD). While neurotransmitter dysregulation and synaptic dysfunction have been well documented in the brains of individuals with ASD, less is known about how these molecular changes manifest in the gut
methodsIn this study, we analyzed RNA signatures in biopsies from the ileum and colon of children with chronic GI symptoms, either with (cases) or without (controls) an autism diagnosis.
resultsGenes associated with serotonin signaling (AANAT, HTR1D, HTR3A, SLC6A4), dopamine synthesis and receptor function (DDC,DRD5), and glutamatergic pathways (GAD2, GRIK3, GLUD1, GRIN2C, SLC1A3, SLC38A1, GABRP, GABRB3, GRM4) were significantly altered in children with ASD, suggesting a broad disruption in neurotransmitter homeostasis in the gut. Additionally,several neuroactive compounds, such as NPY, GIP, NTS, AREG, GKN1, GHRL, LEP, PDYN, and EDN2, were also impacted,further implicating altered neuroimmune interactions and developmental pathways in gut tissues.
conclusionsThese findings highlight the potential role of the gut as a critical modulator of neurodevelopmental processes in ASD and suggest that gut-brain axis dysregulation may contribute to the ASD phenotype. This study provides new insights into the molecular mechanisms in the gastrointestinal tract in individuals with ASD and suggests novel therapeutic targets for restoring healthy gut-brain communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.